This study aims to evaluate the effectiveness of metacognitive therapy (MCT) in reducing fear of cancer recurrence (FCR) among cancer survivors.
With advances in cancer treatment, more patients are surviving cancer. However, many survivors continue to experience fear of cancer recurrence, which can affect their emotional well-being, quality of life, and ability to return to normal daily activities.
In this study, participants will receive a structured psychological intervention adapted from the ConquerFear program. This program has been modified to better fit local cultural needs.
Participants will be randomly assigned to receive either metacognitive therapy or relaxation therapy.
The study will compare the effects of these interventions on reducing fear of cancer recurrence, as well as their impact on emotional distress and quality of life.
The results of this study may help develop effective psychological treatments to support cancer survivors in managing fear of recurrence and improving overall well-being.
Age 18 years or older.
Patients with cancer classified as stage I, II, or III according to the TNM staging system who have completed primary cancer treatment.
Ability to understand and read Chinese, with no significant cognitive impairment.
A score of 13 or higher on a validated measure of fear of cancer recurrence.
Individuals with severe psychiatric disorders.
Individuals who have difficulty communicating in Mandarin. -
Map coordinates are unavailable for these locations. Locations are shown below instead.
Taiwan